Abstract: The present invention relates to salts of budesonide 21-phosphate with ?2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Abstract: The present invention relates to salts of budesonide 21-phosphate with ?2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Abstract: The present invention relates to salts of Montelukast with ?2 adrenergic agonists, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Abstract: The present invention relates to esters of Montelukast with corticosteroids, preferably with des-ciclesonide, triamcinolone, budesonide or flunisolide, pharmaceutical compositions containing the same and the use thereof in the treatment of several respiratory tract diseases, especially asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The invention further relates to the process for preparing said esters.

Abstract: The present invention relates to budesonide 21-phosphate sodium salt for use as anti-inflammatory agent or as anti-asthmatic agent. The invention further relates to pharmaceutical compositions containing the same.

Abstract: The present invention relates to a new process for the preparation of budesonide 21-phosphate and its disodium salt.

Abstract: The present invention relates to salts of budesonide 21-phosphate with ?2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Abstract: The present invention relates to esters of Montelukast with corticosteroids, preferably with des-ciclesonide, triamcinolone, budesonide or flunisolide, pharmaceutical compositions containing the same and the use thereof in the treatment of several respiratory tract diseases, especially asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The invention further relates to the process for preparing said esters.

Abstract: The present invention relates to salts of Montelukast with ?2 adrenergic agonists, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Abstract: The invention provides a system and method of managing service information in a network management system. The method includes the steps of loading the service information from a database into objects in a structure stored in a memory, receiving a change to be made to the service information, updating particular objects in accordance with the received change and sending a change notification to network nodes in accordance with a relationship in the structure between the particular objects.

Abstract: The present invention comprises a method and apparatus for managing nodes of a network. In one embodiment, the invention is implemented as part of a computer based network management system. The system allows a network operator to select, view and modify the configuration of a logical group node at any level of a network hierarchy. The configuration of a logical group node may include, without limitation, logical group node attributes, summary addresses, and any other information that may be relevant to implementing the desired function of a logical group node. After a change is made to the configuration of a logical group node, the system automatically identifies all physical nodes that may potentially function as the logical group node whose configuration has changed, and causes the configurations of the logical group node to be updated on the identified physical nodes to reflect the change made to the logical group node.

Abstract: The invention provides a system and method of managing service information in a network management system. The method includes the steps of loading the service information from a database into objects in a structure stored in a memory, receiving a change to be made to the service information, updating particular objects in accordance with the received change and sending a change notification to network nodes in accordance with a relationship in the structure between the particular objects.

Abstract: The present invention provides a method of provisioning communication service attributes for a subscriber accessing a node in communication network. In an embodiment, the method comprises: (i) creating a profile of said communication service attributes, each of said attributes being assigned a value; and (ii) selectively associating said profile with a particular subscriber for access to said communication network. In another embodiment, the profile of said communication service attributes is embodied in a subscriber service provisioning profile for storing shared subscriber service attributes that are common to a plurality of subscribers in a class; and the subscriber accesses the communication network through a subscriber service, the subscriber service being associated with the subscriber service provisioning profile.